With reference to the earlier intimation dated 03.09.2022 regarding the request received for issuance of duplicate share certificate in lieu of the loss of original share certificate and as required under SEBI Circular No. SEBI / HO / MIRSD / MIRSD_ RTAMB/ P/CIR/ 2022 / 8 dated January 25, 2022, Kimia Biosciences has informed that it enclosed the details of ‘Letter(s) of Confirmation’ issued by the Company to its shareholders, in lieu of share certificate(s) reported as lost by them. The Company has issued duplicate share certificates after verifying all the requisite details of shareholders from Registrar Transfer Agent of the Company. The details of shareholders are envisaged as enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: